Modifying Working Memory With Brain Stimulation

NCT ID: NCT06119620

Last Updated: 2023-11-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

9 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-11-01

Study Completion Date

2024-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators want to investigate the effect of rTMS on working memory measured by the N-back task. This is a single case experimental design, ABAB.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Rationale: The survival rate of patients after cardiac arrest and resuscitation has increased considerably. A common consequence of cardiac arrest is ischemic-hypoxic brain damage leading to cognitive impairment. Currently, there is a lack of knowledge regarding effectiveness of treatments to improve outcomes of patients with cognitive impairment after a cardiac arrest.

Objective: The primary objective is to investigate the effects of rTMS (iTBS protocol) on working memory of people with memory impairments after a cardiac arrest in the past Study design: This will be a single blinded replicated randomized SCED withdrawal designs study.

Study population: Nine adults who had a cardiac arrest in the past will be participating in this study. They are recruited in the general population.

Intervention: If participants are suitable based on the screening. Participants are invited to the university of Maastricht. There they receive intermitted theta burst stimulation with a TMS coil for 3 minutes on the dorsolateral prefrontal cortex. Then they perform the N-back task for 8 to 12 minutes to estimate working-memory performance. Then they have a break (45 min). Then they receive 3 minutes of sham stimulation after which they have to perform the N-back task again for 8 - 12 minutes. This will be repeated (active stimulation - sham - active stimulation - sham).

Main study parameter: The main study outcomes are performance on the N-back task with regard to accuracy.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The participant has to come to the university twice. The screening session takes approximately 1-1,5 hour, the experimental session 3,5 hours. The participant could experience side effects of the rTMS, these include: headache, scalp discomfort, tingling or twitching of the facial muscles, and light-headedness. Serious side effects are very rare, but they may include: seizures. The N-back task can be experienced as tiring.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Arrest Cognitive Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

This is a single case experimental design. All participants will receive both sham and active stimulation. The order of stimulation (sham, active, sham active OR active, sham, active, sham) will be randomised. Also the length of the N-back task is randomised between 8, 10, and 12 minutes).
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

The participant won't be told if they receive sham or active stimulation.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ABAB

all participants will go through sham (control) and active (experimental) stimulation. So either sham - active - sham - active or active - sham - active - sham

Group Type OTHER

intermitted theta burst stimulation

Intervention Type DEVICE

Participants receive intermitted theta burst stimulation for 3-4 minutes before completing the N-back task.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

intermitted theta burst stimulation

Participants receive intermitted theta burst stimulation for 3-4 minutes before completing the N-back task.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

rTMS

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Had a cardiac arrest between 3 months and 5 years prior to the experiment session.
* Scores lower than the general population (corrected for age, education, and sex) on at least one of the cognitive tests ( SD \< -1 on the Stroop, digit span, or TMT).
* Age 18 up to and including 75.
* Proficient in Dutch or English to understand the instructions for the N-back task.
* Has sufficient understanding to perform the N-back task.
* Written informed consent

Exclusion Criteria

* Has a pacemaker or ICD (implantable cardioverter-defibrillator)
* A history or a family member with a history of seizures / epilepsy (asked on the phone and checked on the first appointment).
* Metal implants in or near the head.
* Pregnancy
* Any other neurological disorder impending working memory performance besides the OHCA.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Maastricht University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Caronline v van Heugten, Dr. prof.

Role: PRINCIPAL_INVESTIGATOR

Maastricht University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Maastricht University

Maastricht, Limburg, Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pauline V van Gils, MSc

Role: CONTACT

+31 (0)43 38 84095

Caroline v van Heugten, Dr. prof.

Role: CONTACT

+31 (0)43 388 4213

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pauline van Gils, Drs.

Role: primary

0031433884095

Caroline van Heugten, Prof. Dr.

Role: backup

+31-43-3884090

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BROCA-NIBS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

rTMS and EEG in DOC Patients
NCT04401319 UNKNOWN NA
tDCS in MCS: Repeated Stimulations
NCT02019615 COMPLETED NA